RxDoctor Payments Data

Sankalp Dwivedi

Gastroenterology · Menasha, WINPI 1902215759

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,241 of the $4,575 with a category attached, or 70.9%. 14 manufacturers reported payments, led by Boston Scientific at 31.9% of the total. 2025 is the largest year on record at $1,470, 5.0 times the $294 reported in 2019.

$4,575in general payments, 2019–2025

Across 47 payments — averaging $97.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • AbbVie$1K
  • Gilead$488
  • Sanofi$395
  • Johnson & Johnson$311
  • Janssen Scientific Affairs, LLC$221
  • plus $562 from 8 others

What the payments were for

  • Travel & lodging$1,26628%
  • Food & beverage$3,24171%
  • Education$671%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,575 in reported general payments places this provider in the 85th percentile of 285 gastroenterology providers in Wisconsin.

See all gastroenterology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$57,336
Medicare patients
253
Services billed
417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg654$13,543
Sucralfate18$2,479
Omeprazole102$2,221
Pantoprazole Sodium86$1,313
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl49$995
Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg16$322
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl14$264

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Menasha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →